Interferon-γ has been shown to protect mice from influenza virus if administrated at an early stage of infection (Sainz et al. 2004; Weiss et al. 2010), and genetic variation within the IFNG gene has been linked to SARS in humans (Chong et al. 2006). Here, IFNG is linked to severe acute respiratory syndrome.